DAVID W. GRYSKA

Insider Reports History

Location
Sunnyvale, CA
Signature
/s/ Mark Sullivan, Attorney-in-Fact for David W Gryska
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAVID W. GRYSKA:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mind Medicine (MindMed) Inc. Director Common Shares 19,851 $142,332 $7.17 05 Dec 2024 Direct
Mind Medicine (MindMed) Inc. Director Stock Option (Right to Buy) 75,187 12 Jun 2025 Direct
Forte Biosciences, Inc. Director Stock Option (right to buy) 31,000 20 Mar 2025 Direct
AERIE PHARMACEUTICALS INC Director Common Stock 0 $15.25 21 Nov 2022 By the Gryska Family Trust
AERIE PHARMACEUTICALS INC Director Common Stock 0 $15.25 21 Nov 2022 Direct
AERIE PHARMACEUTICALS INC Director Stock Option (right to buy) 0 $9.14 21 Nov 2022 Direct
GW PHARMACEUTICALS PLC Director Share Options 0 05 May 2021 Direct
Seagen Inc. Director Common Stock 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 14 Dec 2023 Direct

Insider Reports Filed by DAVID W. GRYSKA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNMD Mind Medicine (MindMed) Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:30
FBRX Forte Biosciences, Inc. 20 Mar 2025 1 $0 4 Director 21 Mar 2025, 16:51
MNMD Mind Medicine (MindMed) Inc. 05 Dec 2024 1 +$17,925 4 Director 05 Dec 2024, 16:30
MNMD Mind Medicine (MindMed) Inc. 23 Aug 2024 1 +$20,930 4 Director 26 Aug 2024, 19:00
FBRX Forte Biosciences, Inc. 20 Aug 2024 1 $0 4 Director 22 Aug 2024, 16:11
MNMD Mind Medicine (MindMed) Inc. 10 Jun 2024 1 $0 4 Director 12 Jun 2024, 16:17
/report/000095017023070865-gryska-david-w-2023-12-14 Seagen Inc. 14 Dec 2023 11 -$11,221,687 4 Director 15 Dec 2023, 18:16
FBRX Forte Biosciences, Inc. 19 Sep 2023 1 $0 4 Director 20 Sep 2023, 18:52
FBRX Forte Biosciences, Inc. 31 Jul 2023 1 +$149,999 4 Director 02 Aug 2023, 18:00
MNMD Mind Medicine (MindMed) Inc. 21 Jun 2023 3 $0 4 Director 23 Jun 2023, 18:04
MNMD Mind Medicine (MindMed) Inc. 21 Jun 2023 0 $0 3 Director 23 Jun 2023, 17:00
/report/000120331123000063-gryska-david-w-2023-05-31 Seagen Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 18:22
/report/000120331123000014-gryska-david-w-2023-02-13 Seagen Inc. 13 Feb 2023 2 +$321,125 4 Director 15 Feb 2023, 17:33
FBRX Forte Biosciences, Inc. 10 Jan 2023 1 $0 4 Director 12 Jan 2023, 15:05
FBRX Forte Biosciences, Inc. 10 Jan 2023 0 $0 3 Director 12 Jan 2023, 15:04
/report/000120919122058176-gryska-david-w-2022-11-21 AERIE PHARMACEUTICALS INC 21 Nov 2022 4 -$375,227 4 Director 21 Nov 2022, 15:43
/report/000120331122000059-gryska-david-w-2022-11-11 Seagen Inc. 11 Nov 2022 1 -$968,220 4 Director 15 Nov 2022, 16:46
/report/000120919122036389-gryska-david-w-2022-06-09 AERIE PHARMACEUTICALS INC 09 Jun 2022 2 $0 4 Director 13 Jun 2022, 17:13
/report/000089924322018466-gryska-david-w-2022-05-13 Seagen Inc. 13 May 2022 2 $0 4 Director 17 May 2022, 19:33
/report/000120331122000021-gryska-david-w-2022-04-19 Seagen Inc. 19 Apr 2022 9 -$495,543 4 Director 21 Apr 2022, 18:37
/report/000120331122000013-gryska-david-w-2022-02-07 Seagen Inc. 07 Feb 2022 9 -$534,171 4 Director 09 Feb 2022, 17:58
/report/000120331122000008-gryska-david-w-2022-01-28 Seagen Inc. 28 Jan 2022 12 -$461,269 4 Director 01 Feb 2022, 17:42
/report/000089924322002477-gryska-david-w-2022-01-14 Seagen Inc. 14 Jan 2022 3 -$518,311 4 Director 19 Jan 2022, 17:26
/report/000120919121042040-gryska-david-w-2021-06-17 AERIE PHARMACEUTICALS INC 17 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:39
/report/000120331121000035-gryska-david-w-2021-05-14 Seagen Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 19:31
/report/000089924321018668-gryska-david-w-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 2 $0 4 Director 07 May 2021, 16:19